Transgene Biotek Limited (TRABI.BO)

INR 3.72

(1.92%)

Net Debt Summary of Transgene Biotek Limited

Transgene Biotek Limited's latest annual net debt in 2023 was 139.93 Million INR , up 6.72% from previous year.
Transgene Biotek Limited's latest quarterly net debt in 2023 FY was 139.93 Million INR , up 6.72% from previous quarter.
Transgene Biotek Limited reported annual net debt of 131.12 Million INR in 2022, up 9.28% from previous year.
Transgene Biotek Limited reported annual net debt of 119.98 Million INR in 2021, up 5.95% from previous year.
Transgene Biotek Limited reported quarterly net debt of 135.55 Million INR for 2023 Q2, up 443995.46% from previous quarter.
Transgene Biotek Limited reported quarterly net debt of 139.93 Million INR for 2023 Q4, up 133066.8% from previous quarter.

Annual Net Debt Chart of Transgene Biotek Limited (2023 - 2006)

Historical Annual Net Debt of Transgene Biotek Limited (2023 - 2006)

Year	Net Debt	Net Debt Growth
2023	139.93 Million INR	6.72%
2022	131.12 Million INR	9.28%
2021	119.98 Million INR	5.95%
2020	113.24 Million INR	9.97%
2019	102.98 Million INR	14.01%
2018	90.32 Million INR	-7.34%
2017	97.47 Million INR	-38.9%
2016	159.52 Million INR	7.6%
2015	148.25 Million INR	2.99%
2014	143.95 Million INR	10.68%
2013	130.06 Million INR	-41.82%
2012	223.55 Million INR	7.98%
2011	207.03 Million INR	171.92%
2010	-287.85 Million INR	-292.86%
2009	149.25 Million INR	13.21%
2008	131.83 Million INR	-26.85%
2007	180.22 Million INR	37.27%
2006	131.28 Million INR	0.0%

Year	Net Debt	Net Debt Growth
2023 FY	139.93 Million INR	6.72%
2023 Q2	135.55 Million INR	443995.46%
2023 Q4	139.93 Million INR	133066.8%
2023 Q3	105.08 Thousand INR	-99.92%
2023 Q1	30.52 Thousand INR	-99.98%
2022 Q4	131.12 Million INR	132643.38%
2022 FY	131.12 Million INR	9.28%
2022 Q1	151.22 Thousand INR	-99.87%
2022 Q2	125.43 Million INR	82846.71%
2022 Q3	98.78 Thousand INR	-99.92%
2021 Q4	119.98 Million INR	126095.66%
2021 Q2	115.98 Million INR	47879.91%
2021 FY	119.98 Million INR	5.95%
2021 Q1	241.74 Thousand INR	-99.79%
2021 Q3	95.07 Thousand INR	-99.92%
2020 FY	113.24 Million INR	9.97%
2020 Q1	389.9 Thousand INR	-99.62%
2020 Q3	292.43 Thousand INR	-99.73%
2020 Q2	108.27 Million INR	27669.97%
2020 Q4	113.24 Million INR	38625.76%
2019 Q3	311.32 Thousand INR	-99.68%
2019 FY	102.98 Million INR	14.01%
2019 Q2	97.29 Million INR	0.0%
2019 Q4	102.98 Million INR	32978.48%
2018 FY	90.32 Million INR	-7.34%
2018 Q1	1.01 Million INR	0.0%
2018 Q4	90.32 Million INR	0.0%
2017 FY	97.47 Million INR	-38.9%
2016 FY	159.52 Million INR	7.6%
2015 FY	148.25 Million INR	2.99%
2014 FY	143.95 Million INR	10.68%
2013 FY	130.06 Million INR	-41.82%
2012 FY	223.55 Million INR	7.98%
2012 Q1	65.77 Million INR	0.0%
2012 Q2	123.82 Million INR	88.26%
2012 Q4	223.55 Million INR	71.67%
2012 Q3	130.22 Million INR	5.17%
2011 FY	207.03 Million INR	171.92%
2010 FY	-287.85 Million INR	-292.86%
2009 FY	149.25 Million INR	13.21%
2008 FY	131.83 Million INR	-26.85%
2007 FY	180.22 Million INR	37.27%
2006 FY	131.28 Million INR	0.0%

Peer Net Debt Comparison of Transgene Biotek Limited

Name	Net Debt	Net Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	89.671%
Biocon Limited	140.18 Billion INR	99.9%
Blue Jet Healthcare Limited	-830.93 Million INR	116.841%
Concord Biotech Limited	-372.86 Million INR	137.529%
Dishman Carbogen Amcis Limited	18.99 Billion INR	99.263%
FERMENTA BIOTECH LIMITED	1.1 Billion INR	87.33%
GENOMIC VALLEY BIOTECH LIMITED	-60.73 Thousand INR	230503.069%
Lyka Labs Limited	527.01 Million INR	73.448%
Panacea Biotec Limited	-1.18 Billion INR	111.81%
SAMSRITA LABS LIMITED	21.98 Million INR	-536.369%
Servoteach Industries Limited	5016.00 INR	-2789632.855%
SMS Lifesciences India Limited	992.31 Million INR	85.898%
Supriya Lifescience Limited	-694.68 Million INR	120.144%
Syngene International Limited	-83 Million INR	268.594%
TAKE Solutions Limited	361.37 Million INR	61.277%
Titan Biotech Limited	54.62 Million INR	-156.156%
Vanta Bioscience Limited	607.93 Million INR	76.982%